Literature DB >> 15686301

Management of epistaxis.

Corry J Kucik1, Timothy Clenney.   

Abstract

Family physicians frequently encounter patients with epistaxis (nasal bleeding). In rare cases, this condition may lead to massive bleeding and even death. Although epistaxis can have an anterior or posterior source, it most often originates in the anterior nasal cavity. A directed history and physical examination generally determine the cause of the bleeding. Both local and systemic processes can play a role in epistaxis. Nasal bleeding usually responds to first-aid measures such as compression. When epistaxis does not respond to simple measures, the source of the bleeding should be located and treated appropriately. Treatments to be considered include topical vasoconstriction, chemical cautery, electrocautery, nasal packing (nasal tampon or gauze impregnated with petroleum jelly), posterior gauze packing, use of a balloon system (including a modified Foley catheter), and arterial ligation or embolization. Topical or systemic antibiotics should be used in selected patients. Hospital admission should be considered for patients with significant comorbid conditions or complications of blood loss. Referral to an otolaryngologist is appropriate when bleeding is refractory, complications are present, or specialized treatment (balloon placement, arterial ligation, angiographic arterial embolization) is required.

Entities:  

Mesh:

Year:  2005        PMID: 15686301

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  24 in total

1.  Endotracheal Tube Obstruction via Turbinectomy During Nasal Intubation.

Authors:  Robert Pierre; Harry Dym
Journal:  Anesth Prog       Date:  2018

Review 2.  Pre- and post-operative management of dental implant placement. Part 2: management of early-presenting complications.

Authors:  G Bryce; D I Bomfim; G S Bassi
Journal:  Br Dent J       Date:  2014-08       Impact factor: 1.626

Review 3.  Aetiological profile and treatment outcomes of epistaxis at a major teaching hospital: a review of 721 cases.

Authors:  Brian Carey; Patrick Sheahan
Journal:  Ir J Med Sci       Date:  2017-12-02       Impact factor: 1.568

4.  Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model.

Authors:  Veysel Yurttas; Murat Sereflican; Elçin Hakan Terzi; Gulzade Ozyalvaçlı; Hasan Kazaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-23       Impact factor: 2.503

5.  Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic.

Authors:  Alina Georgiana Anghel; Cristian Costin Soreanu; Mihai Dumitru; Ion Anghel
Journal:  Maedica (Buchar)       Date:  2014-06

6.  Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Volkan Kahya; Orhan Gedikli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

7.  Evaluation of the Relationship Between Blood Pressure Control and Epistaxis Recurrence After Achieving Effective Hemostasis in the Emergency Department.

Authors:  Cheng-Jung Lee; Chen-June Seak; Pin-Chieh Liao; Chia-Hsun Chang; I-Shiang Tzen; Po-Jen Hou; Chih-Chuan Lin
Journal:  J Acute Med       Date:  2020-03-01

Review 8.  Current Approaches to Epistaxis Treatment in Primary and Secondary Care.

Authors:  Rafael Beck; Martin Sorge; Antonius Schneider; Andreas Dietz
Journal:  Dtsch Arztebl Int       Date:  2018-01-08       Impact factor: 5.594

Review 9.  Use of Cryotherapy for Managing Epistaxis in the First Aid Setting: A Scoping Review.

Authors:  David Berry; Jestin N Carlson; Eunice Singletary; David A Zideman; Jennifer Ring
Journal:  Cureus       Date:  2021-05-04

10.  Recurrent and Massive Life Threatening Epistaxis due to Nasal Heroin Usage.

Authors:  Hüseyin Yaman; Yusuf Aydın; Süleyman Yılmaz; Elif Onder; Ender Güçlüm; Ozcan Oztürk
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-02-14       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.